Nitish Aggarwal, MD
Interventional Pain Medicine · Fort Mohave, AZNPI 1518457258
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $9,594 of the $15,176 with a category attached, or 63.2%. Abbott accounts for 67.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $6,228 and has fallen 70.4% since, to $1,846 in 2025.
Across 145 payments — averaging $104.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$10K
- Medtronic$2K
- Biotronik NRO, Inc.$1K
- Stryker$510
- Curonix LLC$479
- Nevro Corp.$286
- plus $796 from 8 others
What the payments were for
- Travel & lodging$9,59463%
- Food & beverage$5,04133%
- Education$5424%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 78 | $10,310 |
| Medtronic | 12 | $1,745 |
| Biotronik NRO, Inc. | 27 | $1,051 |
| Stryker | 4 | $510 |
| Curonix LLC | 4 | $479 |
| Nevro Corp. | 6 | $286 |
| Painteq LLC | 2 | $234 |
| SPR Therapeutics, Inc | 2 | $214 |
| Spinefrontier, Inc. | 1 | $100 |
| MML US, Inc. | 1 | $75 |
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| AbbVie | 2 | $48 |
| Pfizer | 2 | $44 |
| Nalu Medical, Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$8,542
- INTELLIS ADAPTIVESTIM$1,597
- Prospera$804
- SPINEJACK$441
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$366
- PAINTEQ$234
- Omnia$120
- SPRINT PNS System$116
- ETERNA$113
- Senza$107
- InSpan$100
- Sacrix$100
- NanoFuse$100
How this compares
$15,176 in reported general payments places this provider in the 65th percentile of 64 interventional pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 543 | $16,562 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 717 | $11,435 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 444 | $11,282 |
| Naloxone Hcl | 164 | $10,020 |
| OxycontinOxycodone Hcl | 24 | $8,462 |
| Gabapentin | 208 | $3,343 |
| Oxycodone Hcl | 112 | $1,702 |
| Fentanyl | 12 | $1,320 |
| Tramadol Hcl | 226 | $960 |
| Cyclobenzaprine Hcl | 109 | $692 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 14 | $602 |
| Morphine Sulfate ErMorphine Sulfate | 42 | $512 |
| Topiramate | 23 | $294 |
| Tizanidine Hcl | 33 | $234 |
| Methocarbamol | 27 | $229 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Fort Mohave
- Paul LynchScottsdale$283K
- Jack DiepLake Havasu City$233K
- Matthew RansonMesa$86K
- Steven SiwekPhoenix$57K
- Ajay YedduGilbert$52K
- Ramoun JonesPhoenix$51K
- Lisa StearnsPhoenix$48K
- Sachin NarainGilbert$31K
- Jennifer DaisPeoria$30K
- Brandon RothGlendale$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.